These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37712600)

  • 1. Association between plasma lysophosphatidic acid levels and bronchopulmonary dysplasia in extremely preterm infants: A prospective study.
    Li H; Huang Z; Yang C; Han D; Wang X; Qiu X; Zhang Z; Chen X
    Pediatr Pulmonol; 2023 Dec; 58(12):3516-3522. PubMed ID: 37712600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants.
    Chen X; Li H; Qiu X; Yang C; Walther FJ
    BMC Pediatr; 2019 Apr; 19(1):138. PubMed ID: 31039810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality after 36 weeks postmenstrual age of extremely preterm infants in neonatal care: The impact of growth impairment and bronchopulmonary dysplasia.
    Dassios T; Williams E; Hickey A; Bhat R; Greenough A
    Early Hum Dev; 2022 Aug; 171():105618. PubMed ID: 35759944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
    Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ
    Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine Desmosine as a Novel Biomarker for Bronchopulmonary Dysplasia and Postprematurity Respiratory Disease in Extremely Preterm or Low Birth Weight Infants.
    Hirata K; Nishikawa M; Nozaki M; Kitajima H; Yanagihara I; Wada K; Fujimura M
    Am J Perinatol; 2024 May; 41(S 01):e1030-e1036. PubMed ID: 36384237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Bronchopulmonary Dysplasia Among Extremely Preterm Infants in Japan, 2003-2016.
    Nakashima T; Inoue H; Sakemi Y; Ochiai M; Yamashita H; Ohga S;
    J Pediatr; 2021 Mar; 230():119-125.e7. PubMed ID: 33246013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired growth at birth and bronchopulmonary dysplasia classification: beyond small for gestational age.
    Nyp MF; Taylor JB; Norberg M; Truog WE
    Am J Perinatol; 2015 Jan; 32(1):75-82. PubMed ID: 24839148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Packed Red Blood Cell Transfusion as a Predictor of Moderate-Severe Bronchopulmonary Dysplasia: A Comparative Cohort Study of Very Preterm Infants.
    Bolat F; Dursun M; Sarıaydın M
    Am J Perinatol; 2024 May; 41(S 01):e1499-e1507. PubMed ID: 36898407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of time under mechanical ventilation on bronchopulmonary dysplasia severity in extremely preterm infants: a pilot study.
    Escobar V; Soares DS; Kreling J; Ferrari LSL; Felcar JM; Camillo CAM; Probst VS
    BMC Pediatr; 2020 May; 20(1):241. PubMed ID: 32438923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
    Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
    [No Abstract]   [Full Text] [Related]  

  • 11. Vascular endothelial growth factor levels and bronchopulmonary dysplasia in preterm infants.
    Mariduena J; Ramagopal M; Hiatt M; Chandra S; Laumbach R; Hegyi T
    J Matern Fetal Neonatal Med; 2022 Apr; 35(8):1517-1522. PubMed ID: 32366142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of mechanical ventilation and prediction of bronchopulmonary dysplasia and home oxygen in extremely preterm infants.
    Dassios T; Williams EE; Hickey A; Greenough A
    Acta Paediatr; 2021 Jul; 110(7):2052-2058. PubMed ID: 33555069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association between Early Gram-Negative Bacteria in Tracheal Aspirate Cultures and Severe Bronchopulmonary Dysplasia among Extremely Preterm Infants Requiring Prolonged Ventilation.
    Imanishi Y; Hirata K; Nozaki M; Mochizuki N; Hirano S; Wada K
    Am J Perinatol; 2023 Sep; 40(12):1321-1327. PubMed ID: 34359078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced pulmonary oxygen diffusion at 36 weeks of postmenstrual age in small-for-gestational-age preterm infants of less than 32 weeks without bronchopulmonary dysplasia.
    Correani A; Lanciotti L; Giorgetti C; Palazzi ML; Monachesi C; Antognoli L; Burattini I; Cogo P; Carnielli V
    Pediatr Pulmonol; 2023 Nov; 58(11):3054-3062. PubMed ID: 37594147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors and prognosis of bronchopulmonary dysplasia associated pulmonary hypertension in preterm infants].
    Chen C; Huang P; Lin BC; Chen XY; Zhao J; Sun HY; Yu YL; Chen S; Qiu XM; Yang CZ
    Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):747-752. PubMed ID: 32872715
    [No Abstract]   [Full Text] [Related]  

  • 16. Bronchopulmonary dysplasia and postnatal growth following extremely preterm birth.
    Dassios T; Williams EE; Hickey A; Bunce C; Greenough A
    Arch Dis Child Fetal Neonatal Ed; 2021 Jul; 106(4):386-391. PubMed ID: 33334820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early metabolic markers as predictors of respiratory complications in preterm infants with bronchopulmonary dysplasia.
    You Y; Wang L; Liu C; Wang X; Zhou L; Zhang Y; Xia H
    Early Hum Dev; 2024 Mar; 190():105950. PubMed ID: 38301336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D and bronchopulmonary dysplasia in preterm infants.
    Joung KE; Burris HH; Van Marter LJ; McElrath TF; Michael Z; Tabatabai P; Litonjua AA; Weiss ST; Christou H
    J Perinatol; 2016 Oct; 36(10):878-82. PubMed ID: 27467562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
    Potsiurko S; Dobryanskyy D; Sekretar L
    BMC Pediatr; 2021 Jun; 21(1):286. PubMed ID: 34147090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
    JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.